Protective effect of Crassostrea gigas extract on audiogenic seizures in magnesium deficient mice

Biomedicine and Pharmacotherapy

Volumn 52, Issue 4, 1998, Pages 162-165

  Bac, P ^a   Pages, N ^a   Dhalluin, S ^a   Tapiero, H ^a  

^a UNIV PARIS SUD   (France)

Author keywords

Audiogenic seizures; Crassostrea gigas; Magnesium deficiency

Indexed keywords

TISSUE EXTRACT;

ANIMAL MODEL; ARTICLE; AUDIOGENIC SEIZURE; CHEMICAL COMPOSITION; CONTROLLED STUDY; DIET SUPPLEMENTATION; MAGNESIUM DEFICIENCY; MOUSE; NERVE CELL EXCITABILITY; NONHUMAN; OYSTER; PATHOGENESIS; PRIORITY JOURNAL; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0031748018     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(98)80205-9     Document Type: Article

References (15)

1. 1 Durlach J. Magnesium in clinical practice. London: John Libbey; 1988
2. 2 Durlach J, Poenaru S, Bara M, Guiet-Bara A. The control of central neural hyperexcitability in magnesium deficiency. In: Essman WB, ed. Nutrients and brain function. Basel: Karger; 1987. p. 49-71
3. 3 Frings HM, Fuller JL, Ginsburg BE, Ross S, Vicart EM. Standardization of nomenclature describing audiogenic seizures in mice. Behavior 1952 ; 4 : 157-60
4. 4 Bac P, Tran G, Paris M, Binet P. Caractéristiques de la crise convulsive audiogène chez les souris rendues sensibles par carence magnésique. CR Acad Sci 1993 ; 316 : 676-81
5. 5 Bac P, Herrenknecht C, Binet P, Durlach J. Audiogenic seizures in magnesium deficient mice: effects of magnesium pyrrolidone-2-carboxylate, magnesium acetyl taurinate, magnesium chloride and vitamin B6. Magnes Res 1993 ; 6 : 11-19
6. 6 Bac P, Pages N, Herrenknecht C, Teste JF. Effects of Pharmacological oral doses of several magnesium salts on a model of central nervous hyperexcitability due to magnesium deficiency in mice. In: Halpern MJ, Durlach J, eds. Current Research in Magnesium. London: John Libbey; 1996. p 287-91
7. 7 Huxtable RJ. Physiological actions of taurine. Physiol Rev 1992 ; 572 : 101-63
8. 8 Martin DL. Synthesis and release of neuroactive substances by glial cells. Glia 1992 ; 5 : 81-94
9. 9 Benrabh H, Bourre JM, Lefauconnier JM. Taurine transport at the blood-brain barrier: an in vivo brain perfusion study. Brain Res 1995 ; 692 : 57-65
10. 10 Claise C, Edeas M, Abella A et al. Protective effect of Crassostrea gigas extract (JCOE) from oxidative stress in human endothelial and red blood cells Cell. Pharmacology 1996 ; 3 : 337-41
11. 11 Yoshikawa T, Naito Y, Masui K et al. Free radical scavenging activity of Crassostrea gigas extract (JCOE). Biomed. Pharmacother 1997 ; 51 : 328-32
12. 12 Tapiero H, Tew K. Increased glutathione expression in cells induced by Crassostrea gigas extract (JCOE). Biomed Pharmacother 1996 ; 50: 149-53
13. 13 Gaté L, Schultz M, Walsh E et al. Impact of dietary supplement of Crassostrea gigas extract (JCOE) on glutathione levels and glutathione S-transferase activity in rat tissues. In Vivo 1998 ; in press
14. 14 Lampidis TJ, Kolonias D, Tapiero H. Effects of Crassostrea gigas extract (JCOE) on cardiac cell function in vitro: anti-arrhythmic activities. Cell Pharmacol 1996 ; 3 : 241-5
15. 15 Achour A, Lachgar A, Astgen A et al. Potentialization of IL-2 effects on immune cells by oyster extract (JCOE) in normal and HIV-infected individuals. Biomed Pharmacother 1997 ; 51 : 427-30